Apellis Pharmaceuticals Inc (APLS)

11:58 AM

Applying chart zones and confluence areas to Apellis Pharmaceuticals Inc.New Guidance & Safe Entry Momentum Tips - newser.com

11:58 AM

10:50 AM

First Week of December 19th Options Trading For Apellis Pharmaceuticals (APLS) - Nasdaq

10:50 AM

Oct 16, 2025

(APLS) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Oct 16, 2025

Oct 16, 2025

Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results - The Manila Times

Oct 16, 2025

Oct 15, 2025

Apellis Pharma director Dunlop A. Sinclair sells $737k in APLS - Investing.com India

Oct 15, 2025

Oct 15, 2025

Apellis Pharmaceuticals Shares Rise After Wells Fargo Upgrade - MarketScreener

Oct 15, 2025

Oct 15, 2025

Why retail investors pile into Apellis Pharmaceuticals Inc. stockPortfolio Performance Report & Free Accurate Trade Setup Notifications - newser.com

Oct 15, 2025

Oct 15, 2025

Apellis Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com

Oct 15, 2025

Oct 15, 2025

How sentiment analysis helps forecast Apellis Pharmaceuticals Inc.Trade Risk Assessment & Advanced Swing Trade Entry Plans - newser.com

Oct 15, 2025

Oct 15, 2025

Wells Fargo Upgrades Apellis Pharmaceuticals (APLS) to Overweigh - GuruFocus

Oct 15, 2025

Oct 15, 2025

What high frequency data says about Apellis Pharmaceuticals Inc.Quarterly Earnings Report & Real-Time Volume Trigger Notifications - newser.com

Oct 15, 2025

Oct 14, 2025

Earnings call transcript: Apellis Pharmaceuticals Q2 2025 reveals revenue growth - Investing.com Nigeria

Oct 14, 2025

Oct 14, 2025

Apellis Q2 2025 slides: Revenue dips despite EMPAVELI approval for kidney diseases - Investing.com UK

Oct 14, 2025

Oct 14, 2025

APLS Crosses Below Key Moving Average Level - Nasdaq

Oct 14, 2025

Oct 14, 2025

Real time scanner hits for Apellis Pharmaceuticals Inc. explainedMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com

Oct 14, 2025

Oct 14, 2025

Key resistance and support levels for Apellis Pharmaceuticals Inc.Earnings Recap Summary & Daily Profit Maximizing Trade Tips - newser.com

Oct 14, 2025

Oct 13, 2025

Can Apellis Pharmaceuticals Inc. stock surprise with earnings upsideTrade Performance Summary & Target Return Focused Stock Picks - newser.com

Oct 13, 2025

Oct 13, 2025

How to integrate Apellis Pharmaceuticals Inc. into portfolio analysis tools2025 Market Trends & Verified Trade Idea Suggestions - newser.com

Oct 13, 2025

Oct 13, 2025

How to forecast Apellis Pharmaceuticals Inc. trends using time seriesQuarterly Risk Review & Free Expert Verified Stock Movement Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Using R and stats models for Apellis Pharmaceuticals Inc. forecastingDividend Hike & Proven Capital Preservation Tips - newser.com

Oct 13, 2025

Oct 13, 2025

Eastern Bank Cuts Position in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat

Oct 13, 2025

Oct 12, 2025

What analysts say about Apellis Pharmaceuticals Inc stockVWAP Trading Strategies & Master Stock Selection - earlytimes.in

Oct 12, 2025

Oct 10, 2025

Complement 3 Glomerulopathy Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | ChemoCentryx, Novartis, Omeros Corporation, Apellis Pharma - Barchart.com

Oct 10, 2025

Oct 10, 2025

Price momentum metrics for Apellis Pharmaceuticals Inc. explainedQuarterly Trade Summary & Daily Technical Stock Forecast Reports - newser.com

Oct 10, 2025

Oct 10, 2025

Using Bollinger Bands to evaluate Apellis Pharmaceuticals Inc.Quarterly Portfolio Summary & Growth Oriented Trading Recommendations - newser.com

Oct 10, 2025

Oct 10, 2025

Identifying reversal signals in Apellis Pharmaceuticals Inc.2025 Performance Recap & AI Driven Stock Reports - newser.com

Oct 10, 2025

Oct 10, 2025

Fierce Biotech Layoff Tracker 2025: Ascidian Tx trims team; Ferring plots 500 layoffs - fiercebiotech.com

Oct 10, 2025

Oct 10, 2025

How to monitor Apellis Pharmaceuticals Inc. with trend dashboardsJuly 2025 Retail & Reliable Price Breakout Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reiterates Sell (E+) Rating for Apellis Pharmaceuticals (NASDAQ:APLS) - MarketBeat

Oct 09, 2025

Oct 09, 2025

Using data tools to time your Apellis Pharmaceuticals Inc. exitJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com

Oct 09, 2025

Oct 06, 2025

Piper Sandler Maintains Apellis Pharmaceuticals(APLS.US) With Hold Rating, Raises Target Price to $28 - 富途牛牛

Oct 06, 2025

Oct 05, 2025

Published on: 2025-10-05 07:38:09 - newser.com

Oct 05, 2025

Oct 05, 2025

Volume spikes in Apellis Pharmaceuticals Inc. stock – what they meanJuly 2025 Drop Watch & Fast Moving Trade Plans - newser.com

Oct 05, 2025

Oct 05, 2025

Can Apellis Pharmaceuticals Inc. (1JK) stock sustain institutional flows2025 Price Momentum & Smart Money Movement Tracker - newser.com

Oct 05, 2025

Oct 05, 2025

Smart tools for monitoring Apellis Pharmaceuticals Inc.’s price action2025 Market Outlook & Verified Swing Trading Watchlist - newser.com

Oct 05, 2025

Oct 05, 2025

Candlestick signals on Apellis Pharmaceuticals Inc. stock todayWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com

Oct 05, 2025

Oct 04, 2025

J. Safra Sarasin Holding AG Buys 68,588 Shares of Apellis Pharmaceuticals, Inc. $APLS - MarketBeat

Oct 04, 2025

Oct 04, 2025

Wall Street Has a Mixed Opinion on Apellis Pharmaceuticals (APLS) - MSN

Oct 04, 2025

Oct 03, 2025

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Oct 03, 2025

Oct 03, 2025

What Fibonacci levels say about Apellis Pharmaceuticals Inc. reboundTrade Signal Summary & Entry Point Strategy Guides - newser.com

Oct 03, 2025